Answers are grounded in this paper and cite their sources.
The promise of deceased donor management research to deliver innovations that will increase the quantity and quality of organs available for transplant has captivated the collective work of many in the field. Despite this obvious path to harness clinical innovation and drive improvement, the paucity of active protocols is evidence of the continued barriers to conducting this research. In “Disparities in Deceased Organ Donor Research Authorization: Experience at One Organ Procurement Organization and Call for National Conversations,”1 Lentine et al.
No takes yet. Share an insight, caveat, or question.
Glazier et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: